{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T12:24:11Z","timestamp":1791807851075,"version":"4.3.4"},"reference-count":26,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T00:00:00Z","timestamp":1753056000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nephrol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>BK virus-associated nephropathy (BKVAN) is a major complication in kidney transplantation caused by the reactivation of latent BK virus (BKV) under immunosuppression. BKVAN has been strongly associated with increased graft loss. Currently, there is no effective antiviral treatment for BKVAN. Additionally, the development of donor-specific antibodies (DSAs) and the risk of acute and chronic rejection complicate the reduction of immunosuppressive therapy (IS). This case report illustrates the management of BKVAN in a highly sensitized transplant recipient and explores the potential use of extracorporeal photopheresis (ECP) as an immunomodulatory tool.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case<\/jats:title><jats:p>44-year-old Caucasian woman with a history of failed prior transplant and multiple transfusions underwent a second kidney transplant. Due to a high panel-reactive antibody level, she received induction therapy with plasma exchange, thymoglobulin and steroids, followed by maintenance with tacrolimus, mycophenolate mofetil (MMF), and steroids. Initial graft function was good, and protocol biopsies showed no rejection. In year four, the patient developed an increasing BKV viremia (peak of 40,050 copies\/mL) and MMF was reduced, which cleared BKV in six months. Two years later, DSAs reappeared, which led to an increase in MMF. In August 2020 the patient showed a decline of GFR, elevated BKV viremia (peak 162,000 copies\/mL), and a graft biopsy was performed revealing BKVAN. IS was reduced (MMF was discontinued, and tacrolimus was tapered). After eight months, the viremia cleared up, but anti-DR53 DSAs (MFI 16000) levels increased significantly. As the patient was highly sensitized and had a thrombosis of arteriovenous fistula, mTOR inhibitors were not recommended. In order to modulate alloimmunity without further suppressing antiviral immunity, ECP was introduced. Over the next two years, the patient showed stable renal function (eGFR 30\u201340 mL\/min), no recurrence of BKV viremia, and a gradual reduction in DSAs titers. No acute rejection episodes occurred.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>In a highly sensitized patient with BKVAN and contraindications to standard therapies, ECP combined with a tailored immunosuppressive regimen proved effective in controlling viral replication, preserving graft function, and mitigating alloimmune risks. Considering the potential of ECP as an adjunctive therapy in complex BKVAN scenarios, further investigation is warranted.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fneph.2025.1625060","type":"journal-article","created":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T04:10:30Z","timestamp":1753071030000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Case Report: Extracorporeal photopheresis for BK virus nephropathy as a novel treatment for high-risk rejection kidney transplant recipient"],"prefix":"10.3389","volume":"5","author":[{"given":"Marilena","family":"Gregorini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Del Fante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tefik","family":"Islami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Antonietta","family":"Grignano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoletta","family":"Serpieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesare","family":"Perotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Viarengo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Locurcio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Lanotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Tragni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma Diletta","family":"Stea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Martinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Marchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Portalupi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreana","family":"De Mauri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Margiotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora Francesca","family":"Pattonieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grazia","family":"Soccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Rampino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2008.266","article-title":"High frequency of polyoma BK virus shedding in the gastrointestinal tract after hematopoietic stem cell transplantation: a prospective and quantitative analysis","volume":"43","author":"Wong","year":"2009","journal-title":"Bone Marrow Transplant."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.3390\/v14081616","article-title":"BK virus nephropathy in kidney transplantation: A state-of-the-art review","volume":"14","author":"Kant","year":"2022","journal-title":"Viruses"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000001333","article-title":"BK polyomavirus and the transplanted kidney: immunopathology and therapeutic approaches","volume":"100","author":"Lamarche","year":"2016","journal-title":"Transplantation."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1111\/tid.14401","article-title":"Cellular immunity against BK polyomavirus in kidney transplant recipients: A comprehensive review","volume":"27","author":"Al-Talib","year":"2025","journal-title":"Transpl Infect Dis"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000004976","article-title":"The second international consensus guidelines on the management of BK polyomavirus in kidney transplantation","volume":"108","author":"Kotton","year":"2024","journal-title":"Transplantation."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1111\/tid.12952","article-title":"Prediction of BK viremia by urine viral load in renal transplant patients: An analysis of BK viral load results in paired urine and plasma samples","volume":"20","author":"Madden","year":"2018","journal-title":"Transpl Infect Dis"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0238062","article-title":"Kinetics of cytomegalovirus and Epstein-Barr virus DNA in whole blood and plasma of kidney transplant recipients: Implications on management strategies","volume":"15","author":"Lazzarotto","year":"2020","journal-title":"PloS One"},{"key":"B8","article-title":"Intensive antimetabolite reduction is not associated with increasedRisk of biopsy-proven acute rejection in kidney transplantRecipients with BK virus infection; a single center experience","author":"Marvin","year":"","journal-title":"AJT"},{"key":"B9","doi-asserted-by":"publisher","first-page":"101953","DOI":"10.1016\/j.trim.2023.101953","article-title":"Therapeutic strategies against BK polyomavirus infection in kidney transplant recipients: Systematic review and meta-analysis","volume":"81","author":"Zhong","year":"2023","journal-title":"Transpl Immunol dicembre"},{"key":"B10","doi-asserted-by":"publisher","first-page":"CD013344","DOI":"10.1002\/14651858.CD013344.pub2","article-title":"Interventions for BK virus infection in kidney transplant recipients","volume":"10","author":"Wajih","year":"2024","journal-title":"Cochrane Database Syst Rev"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.5500\/wjt.v13.i6.309","article-title":"BK viral infection: A review of management and treatment","volume":"13","author":"Gorriceta","year":"2023","journal-title":"World J Transplant."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3109\/08830185.2013.829470","article-title":"Costimulatory pathways in kidney transplantation: pathogenetic role, clinical significance and new therapeutic opportunities","volume":"33","author":"Esposito","year":"2014","journal-title":"Int Rev Immunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e13931","DOI":"10.1111\/tid.13931","article-title":"Impact of antimetabolite discontinuation following cytomegalovirus or BK polyoma virus infection in kidney transplant recipients","volume":"24","author":"Dubrawka","year":"2022","journal-title":"Transpl Infect Dis"},{"key":"B14","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1002\/jca.21958","article-title":"Immunogenic and immunotolerogenic effects of extracorporeal photopheresis in high immunological risk kidney recipients. A single center case series","volume":"37","author":"Xipell","year":"2022","journal-title":"J Clin Apher."},{"key":"B15","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1186\/s12882-024-03788-4","article-title":"Successful prevention of BK-polyomavirus nephropathy using extracorporeal photopheresis for immunosuppression minimisation following severe BK polyomavirus replication after kidney transplantation in a double lung transplant recipient, a case report","volume":"25","author":"Von Tokarski","year":"2024","journal-title":"BMC Nephrol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2017050477","article-title":"The banff working group classification of definitive polyomavirus nephropathy: morphologic definitions and clinical correlations","volume":"29","author":"Nickeleit","year":"2018","journal-title":"J Am Soc Nephrol."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1097\/TXD.0000000000000641","article-title":"Clearance of BK virus nephropathy by combination antiviral therapy with intravenous immunoglobulin","volume":"3","author":"Kable","year":"2017","journal-title":"Transplant Direct."},{"key":"B18","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3390\/biology10060547","article-title":"Frequency of polyomavirus BK infection in kidney transplant patients suspected to nephropathy","volume":"6","author":"Pakfetrat","year":"2015","journal-title":"Int J Organ Transplant Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/S0377-1237(11)60009-9","article-title":"BK polyoma viral infection in renal allograft recipients","volume":"67","author":"Badwal","year":"2011","journal-title":"Med J Armed Forces India."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2013.07.004","article-title":"Treatment with everolimus is associated with a procoagulant state","volume":"132","author":"Baas","year":"2013","journal-title":"Thromb Res agosto"},{"key":"B21","doi-asserted-by":"publisher","first-page":"100911","DOI":"10.1016\/j.trre.2025.100911","article-title":"Effect of everolimus administration on renal function in renal transplant recipients: A systematic review and dose-response meta-analysis","volume":"39","author":"Ohyama","year":"2025","journal-title":"Transplant Rev (Orlando)."},{"key":"B22","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S1473-0502(03)00103-4","article-title":"Mechanisms of action of extracorporeal photochemotherapy","volume":"29","author":"Heshmati","year":"2003","journal-title":"Transfus Apher Sci agosto"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-1097.1997.tb01895.x","article-title":"Extracorporeal photochemotherapy (photopheresis) induces apoptosis in lymphocytes: a possible mechanism of action of PUVA therapy","volume":"65","author":"Enomoto","year":"1997","journal-title":"Photochem Photobiol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1006\/bcmd.2002.0533","article-title":"Psoralen and UVA light: an in vitro investigation of multiple immunological mechanisms underlying the immunosuppression induction in allograft rejection","volume":"29","author":"Legitimo","year":"2002","journal-title":"Blood Cells Mol Dis"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2007.03372.x","article-title":"In vitro treatment of monocytes with 8-methoxypsolaren and ultraviolet A light induces dendritic cells with a tolerogenic phenotype","volume":"148","author":"Legitimo","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"547","DOI":"10.3390\/biology10060547","article-title":"Photopheresis abates the anti-HLA antibody titer and renal failure progression in chronic antibody-mediated rejection","volume":"10","author":"Gregorini","year":"2021","journal-title":"Biol (Basel)."}],"container-title":["Frontiers in Nephrology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneph.2025.1625060\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T04:10:31Z","timestamp":1753071031000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneph.2025.1625060\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,21]]},"references-count":26,"alternative-id":["10.3389\/fneph.2025.1625060"],"URL":"https:\/\/doi.org\/10.3389\/fneph.2025.1625060","relation":{},"ISSN":["2813-0626"],"issn-type":[{"value":"2813-0626","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,21]]},"article-number":"1625060"}}